GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Liabilities-to-Assets

MedMira (MedMira) Liabilities-to-Assets : 4.60 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is MedMira Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. MedMira's Total Liabilities for the quarter that ended in Jan. 2024 was $15.31 Mil. MedMira's Total Assets for the quarter that ended in Jan. 2024 was $3.33 Mil. Therefore, MedMira's Liabilities-to-Assets Ratio for the quarter that ended in Jan. 2024 was 4.60.


MedMira Liabilities-to-Assets Historical Data

The historical data trend for MedMira's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Liabilities-to-Assets Chart

MedMira Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.44 5.58 5.04 4.23 5.12

MedMira Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.62 4.67 5.12 4.45 4.60

Competitive Comparison of MedMira's Liabilities-to-Assets

For the Biotechnology subindustry, MedMira's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMira's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where MedMira's Liabilities-to-Assets falls into.



MedMira Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

MedMira's Liabilities-to-Assets Ratio for the fiscal year that ended in Jul. 2023 is calculated as:

Liabilities-to-Assets (A: Jul. 2023 )=Total Liabilities/Total Assets
=14.142/2.764
=5.12

MedMira's Liabilities-to-Assets Ratio for the quarter that ended in Jan. 2024 is calculated as

Liabilities-to-Assets (Q: Jan. 2024 )=Total Liabilities/Total Assets
=15.307/3.326
=4.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMira  (OTCPK:MMIRF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


MedMira Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of MedMira's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMira (MedMira) Business Description

Traded in Other Exchanges
Address
155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira (MedMira) Headlines

From GuruFocus

MedMira Reports First Quarter Results FY2023

By ACCESSWIRE ACCESSWIRE 12-31-2022

MedMira Reports First Quarter Results FY2021

By GlobeNewswire GlobeNewswire 12-25-2020

MedMira Reports Third Quarter Results FY2023

By ACCESSWIRE 06-30-2023

MedMira Reports Third Quarter Results

By GlobeNewswire GlobeNewswire 06-30-2018

MedMira Reports Second Quarter Results

By GlobeNewswire GlobeNewswire 03-30-2018

Progress Update on Securities

By ACCESSWIRE 08-31-2023